Listen to The Lancet Neurology

Antonio Uccelli (University of Genoa) discusses his research, published in the November issue of The Lancet Neurology , on the therapeutic use of mesenchymal stem cells for multiple sclerosis.

Priya Palta (Columbia University, New York) explains the importance of blood pressure control in the prevention of cognitive decline. Her Review, published in the October issue of The Lancet Neurology , provides an update of the mounting evidence that links hypertension with dementia risk.

Adam Boxer (University of California, San Francisco) discusses his research, published in the September issue of The Lancet Neurology , on diagnostic performance of tau biomarkers in neurodegenerative diseases.

Irene Cortese (National Institute of Neurological Disorders and Stroke) discusses the difficulties of designing clinical trials in progressive multifocal leukoencephalopathy.

Doug Turnbull (University of Newcastle) discusses mitochondrial diseases in adults, which are reviewed in the July issue of The Lancet Neurology , and explains how important these diseases are for neurologists.

Geert Jan Biessels (University Medical Centre Utrecht) discusses his research, published in The Lancet Neurology  June issue, on using strategic infarct locations to predict post-stroke cognitive impairment.

Henk-Jan Westeneng discusses his new work on the causal effects of pre-symptomatic lifestyle on ALS.

Anne MacGregor discusses her recent Review of menstrual migraine, and explains why this disease needs greater recognition.

Peter Rothwell (Oxford University) discusses his new research, found in our new issue, on asymptomatic carotid stenosis and stroke.

Professor Michael Fehlings discusses the implications of his two papers in the Feb 2021 issue of The Lancet Neurology .

Emma Jones and Simon Mead discuss their article in The Lancet Neurology , identification of novel risk loci and causal insights for sporadic Creutzfeldt-Jakob disease.

Mark Obermann discusses his study examining the use of prednisone for the short-term prevention of cluster headache.

Robert Innis discusses his work on measuring neuroinflammation using PET imaging.

Tom Solomon discusses his Rapid Review on neurologically-associated COVID-19 problems, in  The Lancet Neurology.

Huda Zoghbi discusses the prospects for future therapies in Rett syndrome.

Bas Bloem chats about his new research into a network model for reshaping chronic neurological care for patients with Parkinson's disease.

Sarah Tabrizi discusses her new research into analysing the early onset of Huntington's Disease.

Meng-Chuan Lai discusses the current evidence base for supporting autistic people.

Tobias Derfuss discusses his rapid review on advances in oral immunomodulating therapies in relapsing multiple sclerosis.

Andrea Winkler discusses the global burden caused by stroke, epilepsy, dementia, and neuroinfections, and what low- and middle-income countries can do.

Jonathan Schott discusses the associations between blood pressure across adulthood and late-life brain structure and pathology.

Jeffrey Wozniak talks about his Review in  The Lancet Neurology , on clinical presentation, diagnosis, and management of fetal alcohol spectrum disorder.

Martin Dichgans discusses advancements in the field of stroke genetics.

Brent Fogel talks to  The Lancet Neurology about his work on large-scale genomic analysis.

Amaia Arranz and Bart De Strooper discuss their Review on the role of astroglia in Alzheimer's disease.